Evidence map›Paper›PMID 42726396›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2026

Cinnamaldehyde Attenuates Dehydroepiandrosterone-induced Apoptosis and Inflammatory Responses in a KGN Cell Model of Polycystic Ovary Syndrome.

Jinyan Gao, Xiaodan Weng, Jiali Cheng

Abstract read
PubMed Publisher
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jinyan GaoDepartment of Gynecology and Obstetrics, Qiantang Campus, Zhejiang Provincial Hospital of Integrated Chinese and Western Medicine, No. 98 Yilong Road, Qiantang District, Hangzhou, 311225, Zhejiang Province, China. jinyan_g225@163.com.ORCID http://orcid.org/0009-0006-2887-7471
Xiaodan WengDepartment of Gynecology and Obstetrics, Qiantang Campus, Zhejiang Provincial Hospital of Integrated Chinese and Western Medicine, No. 98 Yilong Road, Qiantang District, Hangzhou, 311225, Zhejiang Province, China.
Jiali ChengDepartment of Gynecology and Obstetrics, Qiantang Campus, Zhejiang Provincial Hospital of Integrated Chinese and Western Medicine, No. 98 Yilong Road, Qiantang District, Hangzhou, 311225, Zhejiang Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polycystic ovary syndrome (PCOS) is a complex reproductive and metabolic disorder characterized in part by chronic low-grade inflammation and granulosa-cell dysfunction. New interventions that protect granulosa cells from hyperandrogenic injury are needed. Cinnamaldehyde (CA), a major bioactive component of cinnamon, has anti-inflammatory and cytoprotective properties; however, its effects in PCOS-related cell models remain unclear. We evaluated CA in human KGN granulosa-like cells treated with dehydroepiandrosterone (DHEA) to establish an in vitro PCOS-like model. CA increased cell viability and EdU incorporation in DHEA-treated cells, reduced the production and expression of TNF-α, IL-1β, and IL-6, and decreased apoptosis. CA also increased PI3K and Akt phosphorylation relative to DHEA treatment alone. These findings indicate that CA attenuates DHEA-induced inflammatory and apoptotic injury in KGN cells and that its effects are associated with restoration of PI3K/Akt signaling. CA therefore warrants further mechanistic evaluation as a potential modulator of PCOS-related granulosa-cell dysfunction.

Indexed as

ApoptosisCinnamaldehydeDehydroepiandrosteroneGranulosa cellsInflammationPI3K/Akt signalingPolycystic ovary syndrome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.